Cetylated Fatty Acids: technologies for muscle and joint well-being
The PharmaNutra Group has invested significant resources to develop a new formulation able to effectively respond to problems relating to the treatment of musculoskeletal conditions. The need comes from our direct dialogue with many professionals in the sports and physiotherapy world, constantly looking for effective and easy-to-use natural products for motor recovery and muscle and joint well-being.
So in 2015, PharmaNutra developed and produced Cetilar® r.m., a complex of highly concentrated Cetylated Fatty Acids (CFA), obtained from the reaction of fatty acids of plant origin with Cetyl Alcohol. The special mechanism of action of Cetylated Fatty Acids not only rapidly reduces joint and musculoskeletal pain but also improves joint function and movement.
In 2022, in addition to Cetilar r.m.® comes Lipocet®, a novel food made with Cetylated Fatty Acids created for the development of oral formulations for muscle and joint well-being.